"Depuis novembre 2019, l’ensemble des installations et des activités de soins du Centre Paul Strauss ont été transférées à l'ICANS | Institut de cancérologie Strasbourg Europe. L’ICANS est un nouvel ensemble hospitalier de référence en cancérologie en Alsace, issu de l’alliance entre le Centre Paul Strauss (CLCC) et les Hôpitaux Universitaires de Strasbourg (CHU)."

During the past decade, Centre Paul Strauss conducted 106 clinical trials. In the 10-year time frame, 106 clinical trials started and 25 clinical trials were completed, i.e. on average, 23.6% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 18 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Paul Strauss" #1 sponsor was "UNICANCER" with 46 trials, followed by "Hoffmann-La Roche" with 19 trials sponsored, "European Organisation for Research and Treatment of Cancer - EORTC" with 16 trials sponsored, "Centre Oscar Lambret" with 9 trials sponsored and "Federation Francophone de Cancerologie Digestive" with 9 trials sponsored. Other sponsors include 111 different institutions and companies that sponsored additional 65 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Paul Strauss" #1 collaborator was "AstraZeneca" with 10 trials as a collaborator, "National Cancer Institute, France" with 10 trials as a collaborator, "Pfizer" with 6 trials as a collaborator, "Hoffmann-La Roche" with 5 trials as a collaborator and "UNICANCER" with 5 trials as a collaborator. Other collaborators include 145 different institutions and companies that were collaborators in the rest 118 trials.

According to Clinical.Site data, the most researched conditions in "Centre Paul Strauss" are "Breast Cancer" (37 trials), "Prostate Cancer" (9 trials), "Colorectal Cancer" (8 trials), "Metastatic Breast Cancer" (7 trials) and "Ovarian Cancer" (7 trials). Many other conditions were trialed in "Centre Paul Strauss" in a lesser frequency.

Most popular intervention types in "Centre Paul Strauss" are "Drug" (143 trials), "Radiation" (48 trials), "Other" (30 trials), "Procedure" (29 trials) and "Biological" (12 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (15 trials), "radiation therapy" (12 trials), "fluorouracil" (11 trials), "Radiotherapy" (9 trials) and "Carboplatin" (8 trials). Other intervention names were less common.

The vast majority of trials in "Centre Paul Strauss" are 147 trials for "All" genders, 59 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Paul Strauss". undefined are not yet recruiting, 29 are recruiting, 35 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 113 completed trials in Centre Paul Strauss, 2 suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Paul Strauss, 13 "Phase 1" clinical trials were conducted, 77 "Phase 2" clinical trials and 79 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 36 trials that are defined as “Not Applicable".